October 18, 2017
Funds further company’s mission to identify and de-risk preclinical rare disease therapeutics, ultimately, spinning out companies with IND-ready programs – Cydan expands leadership team with new chief medical officer and vice president of development Cambridge, Mass., October 17, 2017 – Cydan today announced a new round of financing, raising a committed total of $34 million to advance the company’s...


Danish researchers provide proof: Caesarean sections can lead to asthma and allergies
12. November 2020
Brand-new medical treatment for cocaine addiction
10. November 2020
90 million to 18 Talented Researchers
19. October 2020


Lundbeckfonden Ventures

Lundbeckfonden Emerge